Miia Kivipelto
Psychiatry and Mental health · 2001–2018
A researcher in the Science corpus: 16 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Psychiatry and Mental health — 182 citations into it; #1,266 of 1,338 by trust here, #45 by citations
Whom Miia Kivipelto trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Miia Kivipelto overall
Papers from Miia Kivipelto's perspective
Ordered by how strongly the researchers Miia Kivipelto trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- An 18-year follow-up of overweight and risk of Alzheimer disease. (Archives of Internal Medicine)
- Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (Lancet Neurology)
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
- Alzheimer disease in the US population: prevalence estimates using the 2000 census. (Archives of Neurology)
- Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (Neurology)
- Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease (Annals of Neurology)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- The pathological process underlying Alzheimer’s disease in individuals under thirty (Acta Neuropathologica)
Their papers
- Alzheimer's disease: clinical trials and drug development (2010) — 1,176 citations
- Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease (2018) — 959 citations
- Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria (2016) — 1,741 citations
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 4,590 citations
- Defeating Alzheimer's disease and other dementias: a priority for European science and society. (2016) — 1,473 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) — 1,771 citations
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. (2015) — 2,985 citations
- Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy (2010) — 954 citations
- Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention (2009) — 1,175 citations
- Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. (2006) — 1,041 citations
- Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. (2005) — 1,073 citations
- Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. (2005) — 1,316 citations
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment (2004) — 4,829 citations
- Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. (2004) — 657 citations
- Midlife vascular risk factors and late-life mild cognitive impairment (2001) — 762 citations
- Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study (2001) — 1,682 citations